Artificial sweetener aspartame's FDA approval in 1981 under Ronald Reagan's administration, with Donald Rumsfeld serving as Searle pharmaceutical CEO, raising questions about regulatory conflict of interest.
Aspartame, an artificial sweetener developed by G.D. Searle and Company, received FDA approval on July 18, 1981, after years of regulatory scrutiny and controversy. Donald Rumsfeld served as CEO of G.D. Searle from 1977 to 1985, during the critical period when the company lobbied intensely for aspartame's approval. The FDA had previously rejected aspartame multiple times due to safety concerns raised by independent scientists, including documented tumors in laboratory animals.
The approval process occurred under FDA Commissioner Arthur Hull Hayes Jr., appointed by the Reagan administration in 1981, just months before aspartame's final approval. Rumsfeld's documented influence within Reagan's circle raised questions about regulatory independence. In 1985, Searle was sold to Monsanto for $2.7 billion, and Rumsfeld departed to become Secretary of Defense. Since approval, numerous studies have examined aspartame's safety profile, with some independent research identifying potential health concerns, though regulatory agencies maintain current use levels are safe.
